NCT00802555 2012-07-12Safety Study of ARQ 197 in Cirrhotic Patients With Hepatocellular Carcinoma (HCC)ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)Phase 1 Completed21 enrolled